Follow Us

 FacebookIcon.jpg  TwitterIcon.jpg  YouTubeIcon.jpg  InstagramIcon.jpg

Clinical Trials

Cancer - Breast Cancer

Title
BRCA Mutant Advanced or Metastatic Breast Cancer. EMBRACA
ER Positive, Her2 Negative, Advanced or Metastatic Breast Cancer. C31001.
Eribulin and Pembrolizumab for Metastatic Triple Negative Breast Cancer
HER-2 Positive Breast Cancer With CNS Metastasis. TRIO B-09.
HER2 Positive Early Stage Breast Cancer. PUMA 6201
HER2 Positive Metastatic Breast Cancer for Patients Who Have Received Two or More Prior HER2 Directed Regimens.NALA-PUMA 301
Hormone Receptor Positive, HER2-Negative, Advanced Breast Cancer in Premenopausal Women. MONALEESA 7
Neoadjuvant Study of Abemaciclib in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer. JPBY-neoMONARCH
Neoadjuvant Treatment for Early Stage Triple Negative Breast Cancer. FAIRLANE
Stomatitis Prophylaxis Study for Stage IV Breast Cancer Patients Receiving Everolimus

Cancer - Chronic Lymphocytic Leukemia

Title
CLL and SLL Registry for patients starting treatment

Cancer - Heme Malignancies

Title
CLL 2nd line treatment for High Risk patients. UTX-IB-301
CLL- For Previously Untreated Patients. VICTORIA
Heme Malignancies Serum Collection. BIO-001

Cancer - Lung Cancer

Title
Non Small Cell Lung Cancer Frontline and Maintenance for Advnced or Metastatic Disease. CHECKMATE 370

Cancer - Multiple Myeloma

Title
Newly Diagnosed Multiple Myeloma. Amgen 0482
Relapsed/Refractory Multiple Myeloma. (BMS CA204-142)

Cancer - Non-Hodgkin Lymphoma

Title
Idelalisib in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas. Yosemite
Diffuse Large B-Cell Lymphoma or Follicular Lymphoma that is CD30 Postive Relapsed/Refractory SGN35-023
Frontline Treatment for CD30 Positive Diffuse Large B-cell Lymphoma and Follicular Lymphoma. SGN35-017
Lenalidomide Plus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. MAGNIFY

Cancer - Prostate Cancer

Title
Metastatic Castration Resistant Prostate Cancer. JNJ-56021927

Cancer-Ovarian

Title
Advanced, previously treated Ovarian, Fallopian Tube and Peritoneal Cancer-Quadra 5020

Cancer-Pancreatic

Title
Front line treatment for Metastatic Pancreatic Cancer-CARRIE

Cancer-Renal Cell Carcinoma

Title
Renal Cell Carcinoma-Advanced or Metastatic (Checkmate 374)

Cancer - Breast Cancer

Title
Eisai-208. HER2 Positive Metastatic Breast Cancer

Cancer - GE & Stomach Cancer

Title
GE & Stomach Cancer - MM-111-13-02-04/Merrimack

Cancer - Lung Cancer

Title
NSCLC diagnosis assay development

Cancer - Breast Cancer

Title
Amgen D-Care. Denosumab for Early Stage Breast Cancer
Belle II. HER2 Negative, Metastatic Breast Cancer
For previously treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. MONARCH 1

Cancer - Colorectal Cancer

Title
Previously treated Metastatic Colorectal Cancer. INCB 18424-267.

Cancer - Heme Malignancies

Title
Ublituximab + Ibrutinib in Select B-cell Malignancies.UTX-IB-104
Waldenströms Macroglobulinemia-Open label study for previously treated patients.

Cancer - Hodgkin Lymphoma

Title
Frontline Treatment Trial for Patients With Advanced Classical Hodgkin Lymphoma.C25003

Cancer - Lung Cancer

Title
Advanced or Metastatic Non-Small Cell Lung Cancer.CA209-153.
ARCHER 1042. NSCLC (Stage IIIB/IV) 2nd Line
AZD9291 Expanded Access for T790M mutant Previously treated NSCLC
First line treatment for EGFR Mutant Advanced Non Small Cell Lung Cancer.TIGER-1.

Cancer - Melanoma

Title
A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma. BRIM8.

Cancer - Multiple Myeloma

Title
Champion 2012-002. Multiple Myeloma Relapsing or Progressive Disease.
Elotuzumab Expanded Access Program for Relapsed/Refractory Multiple Myeloma. CA204-143
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma

Cancer - Non-Hodgkin Lymphoma

Title
C05013. First line treatment DLBC Lymphoma
Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas. Bridalveil.

Cancer - Prostate Cancer

Title
NRX194204. Castration and Taxane resistant Prostate Cancer